ABIOMED Story Overview

ABMD -- USA Stock  

USD 446.21  6.57  1.49%

Macroaxis does not monitor all media channels or aggregates social signals for ABIOMED. But even though we do not provide professional-grade financial sentiment analysis on ABIOMED, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for ABIOMED. Check also ABIOMED Hype Analysis, ABIOMED Correlation and ABIOMED Performance.
ABIOMED exotic insider transaction detected
Filed transaction by Abiomed Inc director. Unconventional Insider trading

ABIOMED Inc insider trading alert for general transaction of stock option (right to buy) by Martin Sutter, the corporate stakeholder, on January 3, 2018. This event was filed by Abiomed Inc with SEC on 2018-01-03. Statement of changes in beneficial ownership - SEC Form 4

Cash Floor Correlation

Click cells to compare fundamentals   View All Correlations

Story Momentum

This media report from MacroaxisInsider distributed on January 3, 2018 was a factor to the next trading day price appreciation.The overall trading delta against the next closing price was 1.75% . The overall trading delta when the story was published against the current closing price is 125.26% .

Similar stores for ABIOMED

Advice by Analysts to Buy Healthcare Stock ABIOMED, Inc.news
Street Observer Full coverage
few days ago at www.macroaxis.com 
Acquisition by Kelley Raymond J of 10000 shares of ABIOMED subject to Rule 16b-3
Macroaxis News
Filed transaction by Abiomed Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3
over a week ago at www.macroaxis.com 
ABIOMED exotic insider transaction detected
Macroaxis News
Filed transaction by Abiomed Inc officer. Unconventional Insider trading
over a week ago at http://investorplace.com 
7 A-Rated Stocks to Buy for the Second Half of 2018
news
Investorplace.comFull coverage
over two weeks ago at www.macroaxis.com 
ABIOMED exotic insider transaction detected
Macroaxis News
Filed transaction by Abiomed Inc officer. Unconventional Insider trading
over two weeks ago at www.macroaxis.com 
Acquisition by David Weber of 13000 shares of ABIOMED subject to Rule 16b-3
Macroaxis News
Filed transaction by Abiomed Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3
over three weeks ago at http://www.thewellesleysnews.com 
Analyst Stock Ratings BioTelemetry, Inc. , ABIOMED, Inc.
news
Analyst JournalFull coverage
over three weeks ago at http://ledgergazette.com 
Abiomed Holdings Cut by American Century Companies Inc.
news
The Ledger GazetteWhats Propelling ABIOMED, Inc. to Reach All-Time High Finance News DailyABIOMED, Inc. Reaches 1.36 52-Week High Dignity plc Had 0 Bullish Analysts Key GazetteBenzingas Daily Biotech Pulse FDA Panel Nod For Akcea, Synergys Revenue Miss, FDA Warns E-Liquid Makers Again BenzingaFull coverage
over a month ago at www.macroaxis.com 
Acquisition by Michael Howley of 10000 shares of ABIOMED subject to Rule 16b-3
Macroaxis News
Filed transaction by Abiomed Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3
over a month ago at www.macroaxis.com 
ABIOMED exotic insider transaction detected
Macroaxis News
Filed transaction by Abiomed Inc officer. Unconventional Insider trading
over a month ago at http://finherald.com 
Discover Technical Data and Information of ABIOMED, Inc.
news
Financial HeraldExpedia Del Market Valuation Declined While Hound Partners Has Increased by 1.58 Million Its Holding As ... BZ WeeklyMichael G. Howley Sells 17500 Shares of Abiomed Stock Macon DailyAbiomed Announces Q4 FY 2018 Revenue of 174 Million, Up 40, and Total Year Revenue of 594 Million, Up 33 ... NasdaqFull coverage
over two months ago at http://www.mmahotstuff.com 
Whitestone REIT EPS Estimated At 0.25 Last Week ABIOMED, Inc. Coverage
news
MoneyMakingArticlesFull coverage
over three months ago at http://stocknewstimes.com 
ABIOMED, Inc. Holdings Raised by Jackson Square Partners LLC
news
ABIOMED logo Jackson Square Partners LLC raised its position in ABIOMED, Inc. by 4.2 percent in the 4th quarter, HoldingsChannel reports. Could ABIOMED, Inc. Lose its Strength The Stock Reaches 52-Week High - BZ Weekly Could ABIOMED, Inc. Go Down After Reaching 52-Week High - Frisco Fastball

Did you try this?

Run Premium Stories Now
   

Premium Stories

Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
All  Next Launch Premium Stories

Short Ratio

Short Ratio Comparative Analysis
  Short Ratio 
      ABIOMED Comparables 
ABIOMED is currently under evaluation in short ratio category among related companies. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Check also ABIOMED Hype Analysis, ABIOMED Correlation and ABIOMED Performance. Please also try Bollinger Bands module to use bollinger bands indicator to analyze target price for a given investing horizon.